All head and neck cancer patients are treated in a multi-disciplinary fashion after presentation at a Tumor Board conference. Cutting edge clinical trials are offered to the head and neck cancer patients and personalized medicine is offered for recurrent tumors as all patients tumors are analyzed for actionable genetic targets.
Cherie-Ann Nathan, MD, FACS, is the Jack Pou Endowed Professor and Chairman of the Department of Otolaryngology/Head and Neck Surgery at LSU-Health in Shreveport. She is also Director of Head and Neck Oncologic Surgery and Research at the Feist-Weiller Cancer Center. She completed her Otolaryngology/Head and Neck Surgery residency and head and neck fellowship in 1995 at University of California, San Diego. She was a post-doctoral fellow at Johns Hopkins where she started her research career. Following her fellowship she began her academic career at LSU-Shreveport. Her passion to improve outcomes for patients with HNSCC was the reason she moved from Mumbai India, where she went to TNMC medical school. She is a Surgeon-Scientist that maintains a busy practice treating head and neck cancer patients, thyroid, parathyroid diseases salivary gland tumors and voice disorders and also leads an active research team. All head and neck cancer patients are treated in a multi-disciplinary fashion. Cutting edge clinical trials are offered to head and neck cancer patients and personalized medicine is also offered for recurrent tumors. All patients tumors are analyzed for actionable genetic targets. Her translational research program has been funded by the National Cancer Institute since 2000 and focuses on targeted therapy for head and neck patients. She is nationally and internationally recognized for her seminal work on molecular analysis of surgical margins and has pioneered multi-institutional clinical trials using mTOR inhibitors in HNSCC patients with Wyeth and most recently with Novartis. She is also NIH funded for chemoprevention of cancer with curcumin and has a just been issued a patent for a curcumin gum. She is also a team member of the COBRE grant for viral oncogenesis. She has published extensively and has over 170 publications in peer reviewed journals and has authored textbooks and encyclopedia chapters. Dr. Nathan has served on many National committees some of which include the NCI Steering committee and Task Force, the CDC-American Cancer Society HPV Task Force, board of directors for the Head and Neck Cancer Alliance, ASCO Program committee and Larynx Preservation Guideline Panel and the AAO-HNS Program and Nominating committee and Head & Neck CORE research leader. She has served on many committees for the AHNS including chairing the research, prevention and finance committee and is currently the Vice-President of the American Head and Neck Society. She is also Associate editor for the Laryngoscope Online journal "Laryngoscope Investigative Otolaryngology". At the local level she is active, having been on the board of directors for Shreveport Medical Society, Disaster Reform committee and the Science Museum. The Shreveport-Bossier Commerce Department awarded her the Athena Award for community service and she received the Leonard Tow Humanism award from the Arnold Gold Foundation. The Board of Regents in Louisiana established the "Cherie-Ann Nathan Endowed Professorship in Otolaryngology/Head and Neck Surgery" initiated by grateful patients to honor her dedication and expertise.